Background:
The UK Royal College of Pathologists Thy terminology for reporting thyroid fine-needle aspiration cytology (FNAC), first published in 2009 is used throughout the United Kingdom and Ireland, in some parts of Italy and Switzerland and elsewhere. There is no review of the literature or meta-analysis of the risk of malignancy (ROM) in the various categories of the UK Thy terminology. The goal of this study was to establish the published ROM for each Thy category and compare the results with other existing terminology systems for which similar meta-analyses are available.
Methods:
A comprehensive literature search of online databases was conducted in May 2019 to examine the ROMs for histologically proven nodules with preoperative FNAC classified according to the UK Thy terminology.
Results:
Twenty-five articles were identified that showed results of both cytology and histology. Twelve of these articles were excluded to prevent a selection bias because they showed data in just 1 Thy category. In the remaining 13 articles, the pooled ROMs were as follows: Thy1, 12% (95% confidence interval [CI], 5%-22%); Thy2, 5% (95% CI, 3%-9%); Thy3, 22% (95% CI, 18%-26%); Thy3a, 25% (95% CI, 20%-31%); Thy3f, 31% (95% CI, 24%-39%); Thy4, 79% (95% CI, 70%-87%); and Thy5, 98% (95% CI, 97%-99%).
Conclusions:
This meta-analysis shows results comparable to those of meta-analyses of other internationally recognized reporting terminologies for the pooled ROMs for surgically excised nodules in the various Thy reporting categories. There is comparatively little difference (only 6%) between the pooled ROMs of Thy3a and Thy3f surgically excised nodules.
Citing Articles
Investigation of artificial intelligence-based clinical decision support system's performance in reducing the fine needle aspiration rate of thyroid nodules: A pilot study.
Barnes A, White R, Venables H, Lam V, Vaidhyanath R
Ultrasound. 2024; :1742271X241299220.
PMID: 39654847
PMC: 11625399.
DOI: 10.1177/1742271X241299220.
Prevalence of Thyroid Nodules and Predictive Factors for their Malignancy: Is there any Correlation between Level of TSH and Type of Malignancy?: A Cross Sectional Study.
Moradi L, Hani Tabaei Zavareh M, Zaman F, Shareghi Bruojeni A, Taravati S, Naderi Boldaji H
Adv Biomed Res. 2024; 13:48.
PMID: 39411703
PMC: 11478690.
DOI: 10.4103/abr.abr_158_23.
Thyroid nodules: diagnosis and management.
Grani G, Sponziello M, Filetti S, Durante C
Nat Rev Endocrinol. 2024; 20(12):715-728.
PMID: 39152228
DOI: 10.1038/s41574-024-01025-4.
Unveiling Variations: A Comprehensive Comparison of Five Globally Used Thyroid Cytology Reporting Systems With Histopathological Correlation.
Ramamoorthy S, Boddapati A, Venkata Renuka I, Imandi S, Mounica B
Cureus. 2024; 16(2):e53359.
PMID: 38314381
PMC: 10831778.
DOI: 10.7759/cureus.53359.
Indeterminate thyroid nodules (Thy3): malignancy rate and characteristics in a study of 118 patients.
Dimitriadis P, Moinie A, Michaels J, Bance R, Vijendren A, Mochloulis G
Ann R Coll Surg Engl. 2023; 105(6):568-571.
PMID: 36927065
PMC: 10313444.
DOI: 10.1308/rcsann.2022.0163.
Thyroid Nodules with Indeterminate FNAC According to the Italian Classification System: Prevalence, Rate of Operation, and Impact on Risk of Malignancy. An Updated Systematic Review and Meta-analysis.
Trimboli P, Ferrarazzo G, Cappelli C, Piccardo A, Castellana M, Barizzi J
Endocr Pathol. 2022; 33(4):457-471.
PMID: 36044162
PMC: 9712406.
DOI: 10.1007/s12022-022-09729-x.
Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system: a systematic review and meta-analysis.
Trimboli P, Ferrarazzo G, Piccardo A, Lucchini B, Durante C
Endocrine. 2022; 78(1):24-31.
PMID: 35986840
PMC: 9474526.
DOI: 10.1007/s12020-022-03165-x.
Is repeat fine needle aspiration required in thyroid nodules with initial benign cytology? Results from a large Irish series.
Zia-Ul-Hussnain H, Kgosidialwa O, Kennedy C, Quinn M, Dolan E, Deignan P
BMC Endocr Disord. 2022; 22(1):102.
PMID: 35428234
PMC: 9013082.
DOI: 10.1186/s12902-022-01014-6.
Have We Got Thy3 Wrong in the UK? A Four-Year Single-Site Analysis of Malignancy Rates in Thy3 Nodules.
Chandrasekar B, Jayaram S, de Carpentier J
Cureus. 2022; 13(12):e20125.
PMID: 35003965
PMC: 8723696.
DOI: 10.7759/cureus.20125.
Correlation Between Thyroid Fine Needle Aspiration Cytology and Postoperative Histology: A 10-Year Single-Centre Experience.
Abou-Foul A, Muzaffar J, Diakos E, Best J, Momtahan N, Jayaram S
Cureus. 2021; 13(4):e14504.
PMID: 34007757
PMC: 8123937.
DOI: 10.7759/cureus.14504.
Hürthle Cells on Fine-Needle Aspiration Cytology Are Important for Risk Assessment of Focally PET/CT FDG Avid Thyroid Nodules.
Poller D, Megadmi H, Ward M, Trimboli P
Cancers (Basel). 2020; 12(12).
PMID: 33260994
PMC: 7761140.
DOI: 10.3390/cancers12123544.
Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: a Systematic Review and Meta-analysis.
Ngo H, Nguyen T, Vu T, Jung C, Hassell L, Kakudo K
Endocr Pathol. 2020; 32(2):269-279.
PMID: 32767256
DOI: 10.1007/s12022-020-09643-0.
Risk of Malignancy (ROM) of Thyroid FNA Diagnosed as Suspicious for Malignancy or Malignant: an Institutional Experience with Systematic Review and Meta-Analysis of Literature.
Trimboli P, Fulciniti F, Paone G, Barizzi J, Piccardo A, Merlo E
Endocr Pathol. 2020; 31(1):52-56.
PMID: 31898282
DOI: 10.1007/s12022-019-09602-4.